心脏瓣膜疾病与冠心病同期手术  

Surgery for Combined Valvular and Coronary Atherosclerotic Heart Disease

作　　者：黄旭中[1] 张尔永[1] 

机构地区：[1]四川大学华西医院胸心血管外科,成都610041

出　　处：《中国胸心血管外科临床杂志》2005年第6期422-425,共4页Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

摘　　要：心脏手术和麻醉、心肺转流及心肌保护等相关技术水平的提高,使心脏瓣膜疾病与冠心病同期手术的治疗效果显著提高。但影响同期手术后患者生存的可变因素,包括瓣膜病变的严重程度、冠状血管狭窄支数、左心功能受损害程度、患者年龄和性别的差异等依然存在。现对心脏瓣膜疾病与冠心病同期手术的治疗效果和进展进行综述。Technical advances both in cardiac surgery and relating to anesthesia,cardiopulmonary bypass and myocardial protection have significantly improved the prognosis for patients combined with coronary heart disease and heart valve disease. In addition to technology, variable factors that affect operative survival following combined operation include the severity of valvular disease, the number of coronary vessels affected, impairment of left ventricular function and both age and gender differences. In this article, we review the outcome of surgical intervention for heart valve disease combined with coronary heart disease and discuss future prospects in this field.

关 键 词：心脏瓣膜疾病 冠状动脉粥样硬化性心脏病 同期手术 

分 类 号：R654.2[医药卫生—外科学]